STATLIFE

STATLIFE Logo
114 rue Édouard Vaillant IGR 94800 Villejuif France
Statlife is an innovative company specializing in statistics and data mining applied to Predictive and Preventive Personalized Participative (4P Medicine). MammoRisk, a tool designed for breast cancer assessment, was developed in collaboration with Gustave-Roussy, the biggest comprehensive Cancer Center in Europe, and the BCSC in US. MammoRisk is the subject of a patent application using the "Nearest Neighbor" methodology for the prediction of disease (patent number: EP2278510). Headquartered in Paris, France, with an office in Boston, MA, Statlife is a medical software company specializing in statistical data mining using the 4P Medicine principle: Predictive, Preventive, Personalized, and Participative. MammoRisk, an assessment tool designed to calculate breast cancer risk, was developed in collaboration with Intitut Gustave-Roussy, the largest comprehensive Cancer Center in Europe, and the Breast Cancer Screening Center (BCSC) in the United States. MammoRisk is the subject of a patent application using the "Known Nearest Neighbor" methodology for the prediction of disease (Patent Number: EP2278510). MammoRisk is CE Marked and is FDA approved.